Form EFFECT Qualigen Therapeutics,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 19, 2024 4:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cal Orey Wins 2026 Hollywood Book Awards Best Health & Wellness Honor for The Healing Powers of Honey
- Global Ordnance Holdings and Sparkz Establish First Fully Domestic-Sourced and Manufactured Drone Battery Production
- AmpiFire Issues Guide To Content Marketing vs Traditional PR for Brand Building
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share